OptimizeRx
OPRX
$10.12
Share price
15.00%
Change (1 day)
-31.85%
Change (1 year)
Categories
OptimizeRx (OPRX) - P/B ratio
P/B ratio as of April 2024 : 1.59
According to OptimizeRx's latest financial reports the company has a price-to-book ratio of 1.59.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OptimizeRx - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.24 | -2.09% |
| 2022-12-31 | 2.29 | -72.8% |
| 2021-12-31 | 8.40 | -10.83% |
| 2020-12-31 | 9.42 | 182.7% |
| 2019-12-31 | 3.33 | -53.33% |
| 2018-12-31 | 7.14 | -3.36% |
| 2017-12-31 | 7.39 | 140.16% |
| 2016-12-31 | 3.08 | -22.32% |
| 2015-12-31 | 3.96 | -32.05% |
| 2014-12-31 | 5.83 | -61.29% |
| 2013-12-31 | 15.1 | 40.2% |
| 2012-12-31 | 10.7 | 35.1% |
| 2011-12-31 | 7.95 | 34.91% |
| 2010-12-31 | 5.89 | -79.06% |
| 2009-12-31 | 28.1 | 37.22% |
| 2008-12-31 | 20.5 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Park City Group
PCYG | 3.90 | 146.26% | 🇺🇸 USA |
 LivePerson LPSN | 0.9686 | -38.91% | 🇺🇸 USA |
 Brightcove BCOV | 0.7707 | -51.39% | 🇺🇸 USA |